Switch to:
More From Other Websites
Sanofi Diabetes Drug Suliqua Wins EU Marketing Approval Jan 18 2017
Drugmakers in Davos shift focus to chronic diseases of poor Jan 18 2017
Regeneron, Sanofi Claim Amgen's LDL-Buster Patent Too Broad Jan 17 2017
Sanofi: SuliquaTM Approved in the European Union for the Treatment of Adults with Type 2 Diabetes Jan 17 2017
1:22 pm Sanofi announces that the European Commission has granted marketing authorization in Europe... Jan 17 2017
Key FDA Events to Watch Out for in Q1 Jan 17 2017
5 Trump-Proof Pharma Dividends Up To 5.3% Jan 16 2017
Odds Are Against Regeneron, Sanofi In Amgen Patent Battle: Leerink Jan 13 2017
Sanofi, ImmuNext Sign $500M Autoimmune Drug Pact Jan 13 2017
Insulin Drug Offers Hope for MannKind Jan 12 2017
Regeneron, Sanofi's Drug Manufacturing Plant Cleared Jan 12 2017
Sanofi, ImmuNext Ink Deal, Focus on Autoimmune Diseases Jan 10 2017
The Zacks Analyst Blog Highlights: Clovis Oncology, Pfizer, Roche's, Sanofi and Regeneron... Jan 10 2017
Amgen Inks Multiple Deals, Offers Update on Repatha Lawsuit Jan 10 2017
Sanofi Sees No Opening to Actelion Talks After J&J Re-Entry Jan 09 2017
Morgan Stanley Cuts Regeneron Target On Praluent Patent Worries Jan 09 2017
Impax (IPXL) Applies for Generic Aubagio; Sanofi Files Lawsuit Jan 09 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)